Global Axial Spondyloarthritis (axSpA) Market Report 2023
January 30, 2024 20:24 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis (axSpA) Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global axial...
Global Axial Spondyloarthritis (axSpA) Market Size To Grow USD 10.1 Billion By 2030 | Spherical Insights
April 21, 2023 07:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 21, 2023 (GLOBE NEWSWIRE) -- The Global Axial Spondyloarthritis (axSpA) Market Size is to grow from USD 5.2 billion in 2022 to USD 10.1 billion by 2032, at a Compound...
Axial Spondyloarthritis Management Market is expected to reach US$ 7.3 Billion, & expected to grow with a 5.1% CAGR during 2023 to 2033 | Future Market Insights, Inc.
March 31, 2023 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 31, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Axial Spondyloarthritis management market is expected to grow at a value of 5.1% CAGR, according to...
Axial Spondyloarthritis Pipeline: Drug Pipeline, Regulatory Events and Clinical Trials in the Spotlight| Insights by DelveInsight
June 17, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, June 17, 2021 (GLOBE NEWSWIRE) -- Axial Spondyloarthritis Pipeline: Drug Pipeline, Regulatory Events and Clinical Trials in the Spotlight| Insights by DelveInsight The report offers...
Global Axial Spondyloarthritis (axSpA) Market Landscape Report 2021: Pfizer Leads Industry Sponsors with the Highest Overall Number of Clinical Trials, Followed by AbbVie
June 11, 2021 05:28 ET
|
Research and Markets
Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Axial Spondyloarthritis (axSpA)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...